Clinical Trial Update: Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating ranibizumab for macular edema due to retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Vein Occlusion

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Retinal Vein Occlusion, Treatment | Phase 4 | Status: UNKNOWN